Secukinumab Provides Complete or Almost-Complete Psoriasis Clearance in Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of 4 Phase 3 Trials. J of Skin 2018, 2 (S1), S19. https://doi.org/10.25251/skin.2.supp.19.